ahlam1399
03-16-2016, 09:47 PM
REFILE-UPDATE 1-Amgen beats Sa**fi, Regeneron at cholesterol drug trial
March 16 (Reuters) – A federal jury ruled in favor of Amgen Inc in its lawsuit accusing Sa**fi SA and Regeneron Pharmaceuticals Inc of infringing patents for antibodies related to a cholesterol drug, the defendants said on Wednesday.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e4f903d/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=X9bcr11vZww:Jj6ZKZi-NN0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=X9bcr11vZww:Jj6ZKZi-NN0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=X9bcr11vZww:Jj6ZKZi-NN0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=X9bcr11vZww:Jj6ZKZi-NN0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=X9bcr11vZww:Jj6ZKZi-NN0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/X9bcr11vZww
March 16 (Reuters) – A federal jury ruled in favor of Amgen Inc in its lawsuit accusing Sa**fi SA and Regeneron Pharmaceuticals Inc of infringing patents for antibodies related to a cholesterol drug, the defendants said on Wednesday.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e4f903d/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=X9bcr11vZww:Jj6ZKZi-NN0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=X9bcr11vZww:Jj6ZKZi-NN0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=X9bcr11vZww:Jj6ZKZi-NN0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=X9bcr11vZww:Jj6ZKZi-NN0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=X9bcr11vZww:Jj6ZKZi-NN0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/X9bcr11vZww